FDA-cleared profile
Butterfly Network, Inc.
Butterfly iQ and iQ+ provide handheld general diagnostic ultrasound for adult and pediatric patients; this release adds lung imaging, spectral pulsed-wave Doppler, and automated B-line detection and counting.
Clinical fit
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Implementation
Use these fields to structure a vendor demo, security review, and implementation estimate.
Confirm the controls against the exact contracted architecture and release.
Map the installed model, build, options, population, anatomy, inputs, and outputs to K220068 before acceptance.
exact submission · checked 2026-09-03Later product-family features are not evidence that this cleared release includes them.
Mobile application and transducer workflow with product-family PACS or EMR connectivity; validate supported mobile operating systems, DICOM routing, patient matching, offline behavior, archive completeness, and fleet management.
exact submission · checked 2026-09-03Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The B-line overlay does not diagnose a specific pathology. Users must interpret it with the examination and other clinical data; current iQ+ platform, integration, and security claims may not apply to every K220068 configuration.
exact submission · checked 2026-09-03Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: The B-line overlay does not diagnose a specific pathology. Users must interpret it with the examination and other clinical data; current iQ+ platform, integration, and security claims may not apply to every K220068 configuration.
exact submission · checked 2026-09-03Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.
B-line count and segmentation validation in Butterfly iQ/iQ+ Ultrasound System.
Tested version: Butterfly iQ/iQ+ with Auto B-line Counter cleared in K220068Analytical validation dataset in Butterfly iQ/iQ+ Ultrasound System.
Tested version: Butterfly iQ/iQ+ with Auto B-line Counter cleared in K220068Noninferiority to clinician ground truth in Butterfly iQ/iQ+ Ultrasound System.
Tested version: Butterfly iQ/iQ+ with Auto B-line Counter cleared in K220068Manufacturer multisite analytical validation and pivotal clinical noninferiority evaluation against expert B-line annotations · Adults aged 20-90 with diverse demographic and clinical characteristics
exact submission · Tested version: Butterfly iQ/iQ+ with Auto B-line Counter cleared in K220068 · n=99 · 253 sites · Sponsor or vendor studyK220068
Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.
Economics and lifecycle
These are common procurement questions; unknown values remain visible until a source supports them.
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
No separate named-product payment identified in reviewed public material
Centers for Medicare & Medicaid Services · United StatesBuild a local total-cost and value model; do not infer reimbursement from FDA clearance.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
A zero-result exact-identifier search does not prove that no recall, correction, adverse-event report, or product-family safety signal exists.
Buyer worksheet
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
Recovered from the prior exact-submission extraction and normalized under the current provenance rules. Exact FDA materials, current product-family sources, selected clinical literature, reimbursement context, and exact-identifier recall candidates were reviewed. Pricing, contracted services, enabled options, final security architecture, and local interoperability remain organization-specific evidence. Automated exact-name discovery found 20 PubMed and 10 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Sources
Sources accessed through 2026-09-03.
Alternatives
Samsung Medison CO., LTD.
Samsung V8 is a general diagnostic ultrasound system for broad hospital, clinic, and practice applications; K211945 adds thoracic scanning, AI-based NerveTrack, and AI-based...
Philips Ultrasound, LLC
EPIQ and Affiniti diagnostic ultrasound systems provide the labeled abdominal, cardiac, fetal, pediatric, vascular, cephalic, gynecologic, musculoskeletal, small-organ, urologic,...
Canon Medical Systems Corporation
Aplio i900, i800, and i700 software V9.0 are mobile multi-region diagnostic ultrasound systems for physicians and appropriately trained healthcare professionals; the submission...
Ge Medical Systems Ultrasound and Primary Care Diagnostics
LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal,...